XML 13 R7.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash flows from operating activities:    
Net income $ 111,970 $ 97,122
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization expense 141,405 19,837
Impairment of long lived assets 3,574 0
Reduction in carrying value of operating right-of-use assets 13,077 4,683
Loss on equity method investments 785 274
Charge on interest rate hedge 0 56
Amortization of financing costs and debt discount 5,781 139
Stock compensation expense 18,903 6,394
Deferred tax benefit (34,702) (664)
Unrealized foreign exchange gain (7,323) (1,060)
Other non-cash items (2,895) (744)
Changes in operating assets and liabilities:    
Accounts receivable (35,461) 52,015
Unbilled revenue (55,427) 11,796
Unearned revenue (16,812) (50,079)
Other net assets 84,041 (27,849)
Net cash provided by operating activities 226,916 111,920
Cash flows from investing activities:    
Purchase of property, plant and equipment (19,632) (8,704)
Sale/ (purchase) of investments in equity - long term 96 (599)
Net cash used in investing activities (19,536) (9,303)
Cash flows from financing activities:    
Proceeds from exercise of equity compensation 7,491 5
Share issue costs (3) (5)
Repurchase of ordinary shares (99,983) 0
Share repurchase costs (17) 0
Repayment of bank credit lines and loan facilities (300,000) 0
Net cash used in financing activities (392,512) 0
Effect of exchange rate movements on cash (7,983) (467)
Net (decrease)/ increase in cash and cash equivalents (193,115) 102,150
Cash and cash equivalents at beginning of period 752,213 840,305
Cash and cash equivalents at end of period $ 559,098 $ 942,455